Australia markets closed

Ever Supreme Bio Technology Co., Ltd (6712.TWO)

Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
204.00-0.50 (-0.24%)
At close: 01:30PM CST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
758,391
758,391
627,512
438,841
70,597
Cost of revenue
273,637
273,637
212,955
193,361
88,542
Gross profit
484,754
484,754
414,557
245,480
-17,945
Operating expenses
Research development
99,112
99,112
90,691
84,141
109,248
Selling general and administrative
47,910
47,910
40,071
45,137
29,913
Total operating expenses
147,022
147,022
130,762
129,278
139,161
Operating income or loss
337,732
337,732
283,795
116,202
-157,106
Interest expense
201
201
510
618
778
Income before tax
623,014
623,014
264,103
396,821
-137,398
Income tax expense
83,617
83,617
63,389
27,220
-30,569
Income from continuing operations
539,397
539,397
200,714
369,601
-106,829
Net income
373,781
539,397
200,714
369,601
-106,829
Net income available to common shareholders
539,397
539,397
200,714
369,601
-106,829
Basic EPS
7.64
-
2.68
4.96
-1.58
Diluted EPS
7.60
-
2.66
4.91
-1.58
Basic average shares
74,788
-
74,893
74,575
67,801
Diluted average shares
75,162
-
75,456
75,265
67,801